Global Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) Therapeutics Pipeline Review 2016 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Pipeline Review, H1 2016" report to their offering.

Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) or CTSK is an enzyme encoded by the CTSK gene. It is closely involved in osteoclastic bone resorption and participates partially in the disorder of bone remodeling. It plays an important role in extracellular matrix degradation. The enzyme has the ability to catabolize elastin, collagen, and gelatin, allowing it to break down bone and cartilage.

The Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) pipeline target constitutes close to 7 molecules, out of which approximately 7 molecules are developed by companies. The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1, 3 and 1 respectively.

Cathepsin K - Pipeline Review, H1 2016, outlays comprehensive information on the Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) targeted therapeutics development and features dormant and discontinued projects and the latest news and press releases.

Key Topics Covered:

1. Introduction
2. Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) Overview
3. Therapeutics Development
4. Pipeline Products for Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Overview
5. Pipeline Products for Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Comparative Analysis
6. Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Therapeutics under Development by Companies
7. Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Therapeutics under Investigation by Universities/Institutes
8. Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) Products Glance
9. Late-Stage Products
10. Clinical-Stage Products
11. Early-Stage Products
12. Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Products under Development by Companies
13. Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Products under Investigation by Universities/Institutes
14. Cathepsin K (Cathepsin O or Cathepsin X or EC 3.4.22.38) - Companies Involved in Therapeutics Development

• Amura Holdings Limited
• Medivir AB
• Merck & Co. Inc.
• Virobay Inc.
• Wroclawskie Centrum Badan EIT+ Sp. z o.o.

For more information about this report visit http://www.researchandmarkets.com/research/nqw8nr/cathepsin_k.

Related Topics: Enzymes